IDT Australia Limited announced that Graeme Kaufman has advised the company of his intention to retire and that he does not wish to stand for re-election as a Director at IDT's forthcoming Annual General Meeting. Having held executive roles with CSL Limited and Mesoblast Limited and currently as Chair of Paradigm BioPharmaceuticals Limited, Graeme is well known and regarded within the Australian pharmaceutical and biotech industries. He joined IDT as a Director in June 2013 and was Chair of the Company from October 2013 to November 2017. He is a member of both the Audit and Risk and the Remuneration and Nomination Committees and has also served as an Executive Director.